Haruhiko Shiiya

9PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersOccupational epidemiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 11, 2026
Urinary miR-574-5p as a candidate biomarker for early-stage lung adenocarcinoma: an exploratory case-control study.

|Nov 17, 2025
Preoperative brain natriuretic peptide levels are associated with postoperative all-cause mortality in patients with lung cancer.

Shinya Otsuka, Haruhiko Shiiya, Ryo Takagi

|Jul 21, 2022
Pathological tumor long-to-short axis ratio as a prognostic factor in patients with thymic epithelial tumors.

Dong Tian, Haruhiko Shiiya, Masaaki Sato

|Sep 28, 2021
Elevated serum CYFRA 21-1 level as a diagnostic marker for thymic carcinoma.

Haruhiko Shiiya, Hideki Ujiie, Yasuhiro Hida

|Apr 03, 2021
Lung Transplantation for Pleuroparenchymal Fibroelastosis.

Haruhiko Shiiya, Masaaki Sato

|Feb 12, 2021
Outcomes of lung transplantation for idiopathic pleuroparenchymal fibroelastosis.

Haruhiko Shiiya, Jun Nakajima, Hiroshi Date

Pageof 2

Frequent Collaborators

2 joint publications

Dong Tian

2 joint publications

Hideki Ujiie

2 joint publications

Shinya Otsuka

2 joint publications

Masato Aragaki